ARTICLE
4 August 2016

China's Medical Device Market: Coping With Evolving Regulatory Challenges

RG
Ropes & Gray LLP

Contributor

Ropes & Gray is a preeminent global law firm with approximately 1,400 lawyers and legal professionals serving clients in major centers of business, finance, technology and government. The firm has offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul.
Ask a senior manager of a MedTech company in China what keeps her or him awake at night and "regulatory changes" will invariably be among the first things mentioned.
China Food, Drugs, Healthcare, Life Sciences

Ask a senior manager of a MedTech company in China what keeps her or him awake at night and "regulatory changes" will invariably be among the first things mentioned. In fact, in McKinsey's 2016 survey of MedTech CEOs, regulation tops the list of critical issues MedTech leaders face. Continue reading.

If you would like to discuss the foregoing or any other related matter, please contact Katherine Wang or your usual Ropes & Gray advisor.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More